DIAD: Division of Immunotherapy for Autoimmune Diseases
Feinburg School of Medicine

PATIENTS
Bookmark and Share

The Division of Immunotherapy at Northwestern University has an active program offering promising new therapies using autologous (own cells) and allogeneic (donor cells) hematopoietic stem cell transplantation in treating autoimmune and non-malignant diseases.

The rationale for this treatment is to suppress or destroy the defective immune system and renew it by reinfusing the stem cells. This therapy has led to disease remission and a reestablishment of well being and a return to a quality of life for patients. The Division of Immunotherapy is the premiere center for stem cell transplants in autoimmune and non-malignant diseases. The center has gained an international reputation of excellence and has performed more transplants in this field than any other center in the world.

Most of the patients who qualify for our therapy have failed all other available treatments for their diseases. Autoimmune disorders often impacts young people in their productive years and may be associated with significant morbidity and mortality.
 
Research has led to randomized trials for several of our protocols. Currently the studies for scleroderma, multiple sclerosis, and Type 1 diabetes are randomized trials. Patients under these studies will be randomly selected to either be treated under the “transplant arm” or “treatment arm”. These studies are designed to compare treatment with standard therapies versus high dose immunosuppression followed by stem cell transplant.
Click here for a list of all diagnosis treated.

 

Division of Immunotherapy
Northwestern Memorial
Faculty Foundation

676 N St. Clair, 14th floor
Chicago, IL 60611
312-908-0059
312-908-0064 (Fax)
www.nmff.org
For Patient Information >
Northwestern Memorial Hospital
251 East Huron Street
Chicago, IL 60611
312-926-2000
www.nmh.org



Thank you for your interest in the Division of Immunotherapy at Northwestern University.

We will prevail!

 


 

 

 

 
© 2010 Division of Immunotherapy AND Autoimmune Diseases (DIAD)
Feinberg School of Medicine Northwestern Memorial Hospital Northwestern University